Abstract: This disclosure describes compositions of matter useful as anxiolytic agents and the method of meliorating anxiety in mammals therewith; the active ingredients of said compositions of matter being certain substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines or the pharmacologically acceptable acid-addition salts thereof.
Type:
Grant
Filed:
November 21, 1977
Date of Patent:
September 26, 1978
Assignee:
American Cyanamid Company
Inventors:
George Rodger Allen, Jr., John William Hanifin, Jr., Daniel Bryan Moran, Jay Donald Albright
Abstract: This disclosure describes novel 4-(monoalkylamino)benzonitriles and 5-[4-(monoalkylamino)phenyl]tetrazoles and homologs thereof useful as hypolipidemic and anti-atherosclerotic agents.
Abstract: This disclosure describes a novel series of potent antibacterial agents derived by acylation of antibiotic BM123.gamma. with N-acyloxysuccinimide derivatives.
Abstract: This disclosure describes novel 5-substituted imidazo[1,2-d]-as-triazines useful as anti-asthmatic agents and as inhibitors of the enzyme cyclic-AMP phosphodiesterase.
Abstract: This disclosure describes 5-n-propyl-imidazo[1,2-d]-as-triazin-8(7H)-one and 5-phenyl-imidazo[1,2-d]-as-triazin-8(7H)-one which are useful as anti-asthmatic agents and as inhibitors of the enzyme cyclic-AMP phosphodiesterase.
Abstract: This disclosure describes novel alkyl 3-[6-(aryl)-3-pyridazinyl]-carbazates useful as hypotensive agents in mammals. SPCROSS REFERENCE TO RELATED APPLICATIONSThis application is a continuation of our copending application Ser. No. 692,254, filed June 3, 1976 now abandoned, which in turn is a continuation-in-part of our abandoned application Ser. No. 552,024, filed Feb. 24, 1975 now abandoned.
Type:
Grant
Filed:
August 24, 1977
Date of Patent:
May 30, 1978
Assignee:
American Cyanamid Company
Inventors:
John William Hanifin, Jr., Daniel Bryan Moran, Jay Donald Albright, George Rodger Allen, Jr.
Abstract: This disclosure describes 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamine and novel derivatives thereof and methods of preparation of said compounds. These novel compounds are useful and valuable intermediates for the preparation of 1,2,3,4-tetrahydro-4-oxo(oxy)-1-naphthylurea and thiourea compounds and certain derivatives thereof which are animal growth promoters.
Abstract: This invention relates to novel 1,2,3,4-tetrahydro-4-oxo-[-oxy-]-1-naphthylurea compounds and their derivatives. This invention also relates to method for the preparation of said compounds. This invention further relates to methods for the use of said tetrahydro-4-oxo-[oxy-]-1-naphthylurea compounds as animal growth regulators.
Abstract: There is provided a process for the manufacture of pure cis isomer of 5,6-dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]indoline by the ionic hydrogenation of 5,6-dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]indole.
Abstract: This disclosure describes compositions of matter useful as anti-inflammatory agents and as inhibitors of the progressive joint deterioration characteristic of arthritic disease, and the method of meliorating inflammation and of inhibiting joint deterioration in mammals therewith, the active ingredients of said compositions of matter being benzoylacetonitrile, o-fluorobenzoylacetonitrile, m-fluorobenzoylacetonitrile, p-fluorobenzoylacetonitrile, or mixtures thereof.
Type:
Grant
Filed:
June 17, 1977
Date of Patent:
April 11, 1978
Assignee:
American Cyanamid Co.
Inventors:
Adolph Edward Sloboda, John William Hanifin
Abstract: This disclosure describes compounds of the class of substituted 9-oxoprostanoic acids and the esters and cationic salts thereof, useful as antimicrobial agents, hypotensive agents, anti-ulcer agents, or as intermediates, and novel processes for preparing the same.
Type:
Grant
Filed:
January 4, 1977
Date of Patent:
February 14, 1978
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Karel F. Bernady, Martin J. Weiss
Abstract: This disclosure describes a novel class of antibiotics, three of which have been designated AM31.alpha., AM31.beta., and AM31.gamma. and are produced in a microbiological fermentation under controlled conditions using a new strain of Streptoverticillium netropsis.
Type:
Grant
Filed:
March 8, 1977
Date of Patent:
January 31, 1978
Assignee:
American Cyanamid Company
Inventors:
Jane Parsons Kirby, Donald Bruce Borders
Abstract: Compositions comprising dioctyl calcium sulfosuccinate in a mixture of non-aqueous, i.e. oil, solvents are disclosed as being resistant to crystallization at low temperatures. Dosage units comprising gelatin capsules containing said compositions are also disclosed. The compositions of this invention are useful as fecal softeners.
Abstract: This disclosure describes a novel class of antibiotics, three of which have been designated AM31.alpha., AM31.beta., and AM31.gamma. and are produced in a microbiological fermentation under controlled conditions using a new strain of Streptoverticillium netropsis.
Type:
Grant
Filed:
March 8, 1977
Date of Patent:
December 20, 1977
Assignee:
American Cyanamid Company
Inventors:
Jane Parsons Kirby, Donald Bruce Borders
Abstract: This disclosure describes compositions of matter useful as anxiolytic agents and the method of meliorating anxiety in mammals therewith, the active ingredient of said compositions of matter being 3-methyl-6-phenyl-1,2,4-triazolo[4,3-b]pyridazine or a pharmacologically acceptable acid-addition salt thereof.
Type:
Grant
Filed:
September 22, 1976
Date of Patent:
December 13, 1977
Assignee:
American Cyanamid Company
Inventors:
George Rodger Allen, Jr., John William Hanifin, Jr., Daniel Bryan Moran, Jay Donald Albright
Abstract: This invention relates to ureidotetralin compounds and derivatives and selected enantiomers thereof. This invention also relates to methods for the preparation of said compounds which are useful as animal growth regulators and/or herbicidal agents.
Type:
Grant
Filed:
September 9, 1976
Date of Patent:
December 13, 1977
Assignee:
American Cyanamid Co.
Inventors:
Larry Dean Spicer, Joseph Michael Pensack, Robert Daniel Wilbur, Gary Michael Demkovich
Abstract: This disclosure describes novel 4,5,6,7-tetrahydro-7-iminobenzo[b]thien-4-ylureas, methods of preparation thereof, and methods of use of said compounds for enhancing feed efficiency and for promoting the growth rate of veterinary homothermic animals.
Abstract: This invention relates to 1-benzoyl-3-(4,5,6,7-tetrahydrobenzo[b]thien-4-yl)urea, 1-benzoyl-3-(4,5,6,7-tetrahydro-7-oxobenzo[b]thien-4-yl)urea, and derivatives thereof and a method for the preparation of said compounds and substituted derivatives. Both of the above referred-to compounds are novel and useful intermediates for the preparation of the corresponding tetrahydrobenzo[b]thien-4-ylurea and tetrahydro-7-oxobenzo[b]thien-4-ylurea, respectively. The latter compounds and certain derivatives thereof are animal growth promoting agents.